Full Press Release Details
WATERTOWN, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events:
TD Cowen 45th Annual Healthcare Conference in Boston, MA on March 5 at 9:10 a.m. ET;
Leerink Partners Global Biopharma Conference in Miami, FL on March 11 at 8:00 a.m. ET;
Jefferies Biotech on the Bay Summit in Miami, FL on March 12, one-on-one meetings only; and
H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference on March 27 at 10:30 a.m. ET.
Live webcasts of the presentations will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. Replays of the webcasts will be archived and available following the events.
About Kymera Therapeutics
Tags
Targeted Protein Degradation